Related Experiment Video
Updated: May 19, 2026
04:22
Application of Laparoscopic Hepatectomy Combined with Intraoperative Microwave Ablation in Colorectal Cancer Liver Metastasis
Published on: March 3, 2023
Repeat hepatic resection for colorectal liver metastases.
R A Adair1, A L Young, A J Cockbain
1Department of Hepatobiliary and Transplant Surgery, St James's University Hospital, Beckett Street, Leeds LS9 7TF, UK.
The British Journal of Surgery
|August 7, 2012
Summary
Repeat liver resection offers a curative option for recurrent colorectal liver metastases. Survival rates are favorable, with tumor size being a key predictor of outcomes.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Colorectal Cancer Metastasis
Background:
- Intrahepatic recurrence affects 75-80% of patients after liver resection for colorectal metastases.
- Repeat liver surgery is a viable option for selected patients with recurrent disease confined to the liver.
Purpose of the Study:
- To evaluate the outcomes of repeat liver resection for recurrent colorectal liver metastases.
- To identify clinicopathological factors predicting survival after repeat resection.
Main Methods:
- Retrospective analysis of 195 patients undergoing repeat liver resection at a single tertiary center (1993-2010).
- Assessment of clinicopathological variables and survival data.
Main Results:
- 1-, 3-, and 5-year survival rates were 91.2%, 44.3%, and 29.4%, respectively.
- 30-day mortality was 1.5%, with a 20.0% overall morbidity rate.
- Tumor size ≥ 5 cm was the only independent predictor of overall survival (RR 1.71).
Conclusions:
- Repeat hepatic resection is the sole curative treatment for recurrent colorectal liver metastases.
- Careful patient selection and surgical expertise are crucial for favorable outcomes.
